Cargando…

High affinity FRβ-specific CAR T cells eradicate AML and normal yeloid lineage without HSC toxicity

Acute myeloid leukemia (AML) is an aggressive malignancy, and development of new treatments to prolong remissions is warranted. Chimeric antigen receptor (CAR) T-cell therapies appear promising but on-target, off-tumor recognition of antigen in healthy tissues remains a concern. Here, we isolated a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lynn, Rachel C, Feng, Yang, Schutsky, Keith, Poussin, Mathilde, Kalota, Anna, Dimitrov, Dimiter S, Powell, Daniel J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889499/ https://www.ncbi.nlm.nih.gov/pubmed/26898190 http://dx.doi.org/10.1038/leu.2016.35

Ejemplares similares

Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor
por: Schutsky, Keith, et al.
Publicado: (2015)

Targeting FRβ+ tumor associated macrophages with car T cells in ovarian cancer
por: Lynn, Rachel C, et al.
Publicado: (2015)

The cell fate determinant Llgl1 influences HSC fitness and prognosis in AML
por: Heidel, Florian H., et al.
Publicado: (2013)

CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells
por: Jin, Xin, et al.
Publicado: (2023)

Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies
por: Smith, Jenessa B, et al.
Publicado: (2015)

Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level
por: Song, De-Gang, et al.
Publicado: (2016)

Hierarchical organization and early hematopoietic specification of the developing HSC lineage in the AGM region
por: Rybtsov, Stanislav, et al.
Publicado: (2011)

Emerging CAR T Cell Strategies for the Treatment of AML
por: Vishwasrao, Paresh, et al.
Publicado: (2022)

The Black Hole: CAR T Cell Therapy in AML
por: Atilla, Erden, et al.
Publicado: (2023)

Anti-αFR CAR-engineered NK-92 Cells Display Potent Cytotoxicity Against αFR-positive Ovarian Cancer
por: Ao, Xiang, et al.
Publicado: (2019)

Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies
por: Poussin, Mathilde, et al.
Publicado: (2021)

Stability, affinity and chromatic variants of the glutamate sensor iGluSnFR
por: Marvin, Jonathan S., et al.
Publicado: (2018)

Biomarkers as targets for CAR-T/NK cell therapy in AML
por: Shao, Ruonan, et al.
Publicado: (2023)

The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor Efficacy
por: Chacon, Jessica Ann, et al.
Publicado: (2016)

CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
por: Rodriguez-Garcia, Alba, et al.
Publicado: (2021)

Eradication of Measurable Residual Disease in AML: A Challenging Clinical Goal
por: Bernasconi, Paolo, et al.
Publicado: (2021)

CD70 CAR T cells in AML: Form follows function
por: Mirazee, Justin, et al.
Publicado: (2022)

Genetic affinities of an eradicated European Plasmodium falciparum strain
por: de-Dios, Toni, et al.
Publicado: (2019)

Single Cell Transcriptomics to Understand HSC Heterogeneity and Its Evolution upon Aging
por: Hérault, Léonard, et al.
Publicado: (2022)

Heterocyclic Substitutions Greatly Improve Affinity and Stability of Folic Acid towards FRα. an In Silico Insight
por: Al-Thiabat, Mohammad G., et al.
Publicado: (2021)

Conjugated β-Cyclodextrin Enhances the Affinity of Folic Acid towards FRα: Molecular Dynamics Study
por: Al-Thiabat, Mohammad G., et al.
Publicado: (2021)

head-bent resistant Hsc70 variants show reduced Hsp40 affinity and altered protein folding activity
por: Papsdorf, Katharina, et al.
Publicado: (2019)

In vivo generated human CAR T cells eradicate tumor cells
por: Agarwal, Shiwani, et al.
Publicado: (2019)

Hsc70’s trip to the tip
por: Leslie, Mitch
Publicado: (2015)

Thrombopoietin: tickling the HSC's fancy
por: Kim, Ah Ram, et al.
Publicado: (2017)

Fr hjahrstagung
por: Schötzau, H J
Publicado: (1994)

Structure of clathrin coat with bound Hsc70 and auxilin: mechanism of Hsc70-facilitated disassembly
por: Xing, Yi, et al.
Publicado: (2010)

Awakening the HSC: Dynamic Modeling of HSC Maintenance Unravels Regulation of the TP53 Pathway and Quiescence
por: Ikonomi, Nensi, et al.
Publicado: (2020)

Mast Cell Repopulating Ability Is Lost During the Transition From Pre-HSC to FL HSC
por: Yoshimoto, Momoko, et al.
Publicado: (2022)

Comparative analysis of the anticoagulant activities and immunogenicity of HSC70 and HSC70(TKD) of Haemaphysalis flava
por: Liu, Yu-Ke, et al.
Publicado: (2022)

Evaluation of switch-mediated costimulation in trans on universal CAR-T cells (UniCAR) targeting CD123-positive AML
por: Meyer, Jan-Erik, et al.
Publicado: (2021)

Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
por: Hofmann, Susanne, et al.
Publicado: (2019)

Adapter CAR T cells to counteract T-cell exhaustion and enable flexible targeting in AML
por: Nixdorf, D., et al.
Publicado: (2023)

FR-CAPTCHA: CAPTCHA Based on Recognizing Human Faces
por: Goswami, Gaurav, et al.
Publicado: (2014)

Decay chains of $^{202}Fr$ and $^{204}Fr$ and $\alpha$ decay branches
por: Bingham, C R, et al.
Publicado: (1995)

Filgrastim-Associated Pneumonitis in Cancer Patient Undergoing Hematopoietic Stem Cell (HSC) Mobilization for Autologous-HSC Transplantation
por: Patel, Drashti R, et al.
Publicado: (2020)

A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy
por: Epperly, Rebecca, et al.
Publicado: (2020)

Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
por: Marofi, Faroogh, et al.
Publicado: (2021)

Rapamycin Pretreatment Rescues the Bone Marrow AML Cell Elimination Capacity of CAR-T Cells
por: Nian, Zhigang, et al.
Publicado: (2021)

Recent Advances in the Development of Anti-FLT3 CAR T-Cell Therapies for Treatment of AML
por: Pedersen, Maya Graham, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0gr120kis6kt2n65iqismq7lvr